SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 213 filers reported holding SEATTLE GENETICS INC in Q4 2014. The put-call ratio across all filers is 1.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $27,799,000 | +38.9% | 526,785 | +42.1% | 0.03% | +33.3% |
| Q3 2016 | $20,018,000 | +33.2% | 370,627 | -0.3% | 0.02% | +40.0% |
| Q2 2016 | $15,023,000 | +15.6% | 371,755 | +0.4% | 0.02% | +7.1% |
| Q1 2016 | $12,995,000 | +4.1% | 370,334 | +33.1% | 0.01% | +7.7% |
| Q4 2015 | $12,488,000 | +34.9% | 278,255 | +15.9% | 0.01% | +30.0% |
| Q3 2015 | $9,258,000 | -17.3% | 240,099 | +3.9% | 0.01% | -16.7% |
| Q2 2015 | $11,188,000 | +36.9% | 231,156 | 0.0% | 0.01% | +50.0% |
| Q1 2015 | $8,171,000 | +10.0% | 231,156 | 0.0% | 0.01% | +14.3% |
| Q4 2014 | $7,427,000 | -73.6% | 231,156 | -69.4% | 0.01% | -75.0% |
| Q3 2014 | $28,123,000 | -48.4% | 756,401 | -46.9% | 0.03% | -46.2% |
| Q2 2014 | $54,476,000 | -16.2% | 1,424,197 | -0.2% | 0.05% | -18.8% |
| Q1 2014 | $64,984,000 | +0.6% | 1,426,337 | -11.9% | 0.06% | +3.2% |
| Q4 2013 | $64,603,000 | -27.0% | 1,619,546 | -19.8% | 0.06% | -30.3% |
| Q3 2013 | $88,491,000 | +26.0% | 2,018,966 | -9.5% | 0.09% | +20.3% |
| Q2 2013 | $70,212,000 | – | 2,231,771 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 51,049,760 | $3,738,884,000 | 23.93% |
| Lagoda Investment Management, L.P. | 76,873 | $5,630,000 | 7.16% |
| Matrix Capital Management Company, LP | 3,141,852 | $230,109,000 | 6.14% |
| DOMINI IMPACT INVESTMENTS LLC | 3,120 | $229,000 | 3.51% |
| Opus Point Partners Management, LLC | 17,832 | $1,306,000 | 1.77% |
| Capital International Sarl | 188,200 | $13,784,000 | 1.72% |
| EMORY UNIVERSITY | 33,368 | $2,444,000 | 1.72% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 60,900 | $4,460,000 | 1.65% |
| CAPITAL GUARDIAN TRUST CO | 1,358,254 | $99,415,000 | 1.32% |
| Rhenman & Partners Asset Management AB | 150,598 | $11,030,000 | 1.29% |